Previous 10 | Next 10 |
GERMANTOWN, Md., April 04, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer, manufacturer and service provider of advanced cell therapies, today announced that it has entered into a collaboration agreement with Digilab Inc. to develop a live cell printing process and syst...
GERMANTOWN, Md., April 03, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced the publication of an independent study, entitled “The Role of The Vasculature Niche on Insulin Producing Cell...
GERMANTOWN, Md., March 28, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced that it has entered into a Master Service and Joint Venture Agreement (the “JV”) with TheraCell Adv...
Orgenesis (OTCQB: ORGS) is a biotechnology company specializing in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry, according to the company’s website (see here: www.orgenesis.com ). SNNLive caught up with Vered Ca...
I have been studying what effect uplisting has on the stock price of individual stocks. My first article concluded that a profit exceeding 25% was available in 65% of stocks that had uplisted during 2015 but that profit evaporated within the first year after uplisting. Only 10% of these same...
GERMANTOWN, Md., March 25, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced plans to establish a new, state-of-the-art production site for its Masthercell Global subsidiary, designed to...
GERMANTOWN, Md., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer, manufacturer and service provider of advanced cell therapies, today reported financial results and provided a business update for the fiscal year ended November 30, 2018. Fiscal Year 2018 Fina...
GERMANTOWN, Md., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer, manufacturer and service provider of advanced cell therapies, today announced that Vered Caplan, Chief Executive Officer, will participate in a panel, “New Treatments for Diabetes and Obesi...
GERMANTOWN, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced that Orgenesis’ Chief Scientific Officer, Sara Ferber Ph.D. will present the Company's novel and proprietary au...
GERMANTOWN, Md., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced the opening of new offices and laboratories at Accessia Pharma in Liège, Belgium for its Belgian subsidiary, Orge...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.7% to $127.255 on volume of 88,797,787 shares Ascent Solar Technologies Inc (ASTI) rose 9.6% to $0.1183 on volume of 88,651,038 shares Crown Electrokinetics Corp. (CRKN) fell 19.0% to $0.040499 on volu...